A study appearing in Nature investigated the role of astrocytes, an abundant cell type in the brain, in regulating an immune ...

Researchers at the University of Michigan Health Rogel Cancer ... model, they also identified a potential inhibitor, DDR1-IN-1, which appears to dismantle oncostreams. Preliminary studies in a ...

Lantern Pharma Inc. (NASDAQ:LTRN)’s investigational drug LP-184 has achieved a major milestone in the fight against pediatric ...

The scientists showed how the immune cells could eliminate a deadly brain tumor called glioblastoma and prevent recurrences. They also used the cells to tamp down inflammation in a mouse model of ...

Our study investigated the role of astrocytes, an abundant cell type in the brain, in regulating an immune response against ...

Share on Pinterest Could an experimental cancer vaccine successfully target aggressive brain tumors ... results testing the new therapy in a mouse model of glioblastoma. The study was recently ...

A group at the University of Pennsylvania (UPenn) is using this model to test tumor response to novel immunotherapies. In the study, researchers resection the brain tumor and used those cells to ...

The team tested their dual-action, cancer-killing vaccine in an advanced mouse model of the deadly brain cancer glioblastoma, with promising results. Findings are published in Science ...

They also found that inhibiting the protein significantly reduces the development of brain metastases in a mouse model. The study recently appeared in the journal Nature Cancer. Sometimes cancer ...

Medication delivered by a novel gel cured 100% of mice with an aggressive brain ... cancer cells and suppress tumor growth. The results are published in Proceedings of the National Academy of Sciences ...

When Filbin’s team tested avapritinib in an animal model of HGG, they found that the drug penetrated the brain and decreased tumor growth. These findings motivated the study team to expand the ...